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We report the eﬀects of a Mediterranean-style diet, with or without calorie restriction, on biomarkers of aging and oxidative stress
in overweight men. 192 men were randomly assigned to either a Mediterranean-style diet or a conventional diet. The intervention
program was based on implementation of a Mediterranean dietary pattern in the overweight group (MED diet group), associated
with calorie restriction and increased physical activity in the obese group (lifestyle group). Both groups were compared with
participants in two matched controlgroups (advice groups). After 2 years, there was a signiﬁcantdiﬀerence in weight loss between
groups, which was −14kg (95% CI −20 to −8) in lifestyle groups and −2.0kg (−4.4 to 0) in the advice groups, with a diﬀerence
of −11.9kg (CI −19 to −4.7kg, P<. 001); moreover, there was a signiﬁcant diﬀerence between groups at 2 years for insulin
(P = .04), 8-iso-PGF2α (P = .037), glucose (P = .04), and adiponectin (P = .01). Prolonged adherence to a Mediterranean-style
diet, with or without caloric restriction, in overweight or obese men is associated with signiﬁcant amelioration of multiple risk
factors, including a better cardiovascular risk proﬁle, reduced oxidative stress, and improved insulin sensitivity.
1.Introduction
Data from observational and cohort studies indicate that
longevityisgreaterinindividualsadheringtohealthylifestyle
practices [1] or in those with a favorable level of risk factors
[2,3].Becauseofthelimitationsinfeasibilityforrandomized
trials to address the long-term eﬀects of lifestyle on clinical
outcomes, clinicians must rely mainly on a combination of
epidemiological investigations and short-term clinical trials
with intermediate end points. Whether long-term lifestyle
changes add years to life and slow aging is not yet known.
Some recent ﬁndings suggest that calorie restriction may
have a positive eﬀect on surrogate markers of longevity,
including fasting insulin level and body temperature, as
well as markers of oxidative stress [4]. Although the data
were based on small number of subjects and limited follow-
up (up to six months), the results were in line with the
hypothesis that decreasing caloric intake by 30% or more
in young or middle-aged laboratory animals prevents or
retards age-related chronic diseases and signiﬁcantly pro-
longs maximal lifespan [5, 6].The qualityofdietmayalso be
important, as secondary prevention trials have indicated that
Mediterranean-style diets reduced rates of heart disease and
cardiovascular mortality in people with established coronary
diseases [7, 8]. Moreover, increasing evidence suggests that
diet may also be important in modulating inﬂammation
[9, 10]. We are not aware of any trials assessing the long-
term eﬀect of the quality of diet on markers of longevity
or oxidative stress in primary prevention. We report the
eﬀects of a Mediterranean-style diet, with or without calorie
restriction, on biomarkers of aging and oxidative stress in
overweight men.
2.Methods
2.1. Study Participants. Men were identiﬁed in our database
ofsubjectsparticipatinginrandomizedcontrolledtrialseval-
uating the eﬀect of lifestyle changes [11, 12] and conducted2 Cardiology Research and Practice
from October 2000 to January 2004. Men included in the
presentanalysis were obesesubjectswith erectiledysfunction
[11] or overweight subjects with metabolic syndrome [12]
and had to have a complete follow-up in the respective study
trial.
Participants were recruited from the outpatient practices
of the Teaching Hospital of the Second University of Naples,
Italy,and includedpersonsof18yearsofageandolderwith a
body mass index (BMI) of 26kg/m2 or greater. The subjects
were sedentary (less than one hour per week of physical
activity) with no evidence of participation in diet reduction
programs and with a stable weight (±1kg) within the last
6 months. The exclusion criteria were diabetes mellitus,
impaired renal function (serum creatinine level greater
than 1.5mg/dL), hepatic disease, cardiovascular disease,
psychiatric problems,ahistoryofalcoholabuse(atleast500g
alcohol/week in the last year), and use of any medication.
Subjects with the metabolic syndrome had to have three or
more of the criteria recommended by the Adult Treatment
Panel [13]. The study was approved by the institutional
committee of ethical practice of our institution, and all the
study subjects gave informed written consent.
2.2. Interventions. The intervention program was based on
implementation of a Mediterranean dietary pattern in the
overweight group (MED diet group), combined with calorie
restriction and increased physical activity in the obese group
(lifestyle group). Both groups were compared with two
matched control groups (advice groups). Subjects were ran-
domly assigned to either the intervention or advice groups
using a computer-generated random number sequence. The
program involved education on reducing dietary calories,
personal goal setting, and self-monitoring (food diaries)
through a series of monthly small-group sessions. The
recommended composition of the dietary regimen was the
following: carbohydrates 50% to 60%, proteins 15% to 20%,
total fat ≤ 30%, saturated fat < 10%; subjects were also
advised to increase consumption of fruits, vegetables, nuts,
and whole grains daily, and to increase the consumption of
olive oil. Patients were in the program for 24 months and
had monthly sessions with the nutritionist for the ﬁrst year
andbimonthlysessions forthesecondyear. Compliancewith
the program was assessed by attendance at the meetings and
completion of the diet diaries. Subjects in the lifestyle group
also received guidance on increasing their level of physical
activity, mainly walking for a minimum of 30 minutes per
day, but also swimming or aerobic ball games. Subjects
in the advice groups were given general oral and written
information about healthy food choices both at baseline and
at subsequent visits, but no speciﬁc individualized programs
were oﬀered to them.
2.3. OutcomeMeasures. Outcomemeasures were recorded at
one and two years. The primary end point was change from
baseline in insulin and 8-iso-PGF2α between intervention
and advice groups. Secondary analyses included the changed
from baseline in body weight, total cholesterol, blood
pressure, glucose, and adiponectin.
Height and weight were recorded with participants
wearing lightweight clothing and no shoes using a Seca 200
scale with attached stadiometer (Seca, Hamburg, Germany).
Twenty-four-hour nutrient intakeswere calculatedwith food
composition tables and patients’ weekly diet diaries. All
subjects were asked to complete for 3-day food record and
to record occupational, household, and leisure time physical
activity, to assess dietary adherence and exercise activity.
Estimation of insulin sensitivity in the fasting state was
assessed with HOMA (homeostasis model assessment) and
calculatedwith thefollowing formula:fasting plasma glucose
(mmol/L) × fasting serum insulin (μU/mL)/25, as described
by Matthews et al. [14]. Assays for serum total and high-
density lipoprotein cholesterol, triglycerides, and glucose
levels were performed in the hospital’s chemistry laboratory.
Plasma insulin levels were assayed by radioimmunoassay
(Ares, Serono). Serum samples for adiponectin were stored
at −80◦C until assayed in duplicate using a high-sensitive,
quantitative sandwich enzyme assay (Quantikine HS, R&D
Systems, Minneapolis, MN). Plasma total 8-iso-PGF2α levels
were assessed by enzyme immunoassay (Assay Design Inc.,
Indianapolis, IN).
2.4. Statistical Analysis. Data are presented as mean ±
SD unless otherwise stated. Unpaired (intervention versus
advice) and paired (before versus after treatment) Student’s
t-tests were performed. The eﬀect of treatments were tested
by means of paired t-tests and a Wilcoxon matched test.
The results of statistical analysis were also conﬁrmed with
ANOVA for repeated measures. Results were considered
significant with two-tailed P<. 05. All analyses were
conducted using SPSS version 11.1 (SPSS Inc, Chicago, Ill).
3.Results
A total of 192 men enrolled in the study, 98 men in the
intervention groups (46 MED diet, 52 lifestyle) and 94
men (44 MED diet, 50 lifestyle) in the advice groups. Both
intervention groups were comparable with the correspond-
ing advice groups, including the number of components
of the metabolic syndrome, and relatively healthy. The
prevalenceofsmokerswassimilarinthe2groups:27%inthe
intervention group and 31% in the control group (P = .34).
Moreover, baseline data showed no important diﬀerence in
thenutrientintakebetweenthetwogroups(datanotshown).
After 2 years, subjects on the intervention groups consumed
a greater percentage of calories from complex carbohydrates,
polyunsaturated, and monounsaturated fat, had higher ﬁber
intake, a lower ratio of omega-6 to omega-3 fatty acids,
as well as lower energy consumption, saturated fat, and
cholesterol intake than controls. Total fruit, vegetable, nuts,
and whole grain intakes and olive oil consumption were
signiﬁcantly higher in the intervention groups. The level of
physical activity increased more in the intervention group
(from 39 [10] to 156 [30] min/wk) than in the control group
(from 41 [9] to 74 [28] min/wk; P<. 001).
After 2 years, there was a signiﬁcant diﬀerence in weight
loss between groups, which was −14kg (95% CI −20 to −8)Cardiology Research and Practice 3
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Figure 1: Changes in fasting plasma total cholesterol, glucose, insulin, mean blood pressure, insulin, adiponectin, and 8-iso-PGF2α levels
at year 1 and year 2 in subjects of intervention groups (black columns: lifestyle, white columns: MED diet). All parameters represent the
net eﬀect (intervention group, advice group) of treatments and were signiﬁcantly reduced from baseline values at year 1 and year 2 in both
groups.
in lifestyle groups and −2.0kg (−4.4 to 0) in the advice
groups, with a diﬀerenceof −11.9kg(CI −19 to −4.7kg, P<
.001). There was a signiﬁcant association between change in
body weight and HOMA (r = 0.43, P = .01), as well as
between waist and HOMA (r = 0.37, P = .01).
Figure 1 shows the eﬀect of treatments (change in
intervention groups minus change in advice groups) on
selected parameters at one year and two years. The eﬀect of
treatment was sustained as there was no trend to decrease at
2 years; moreover, there was a signiﬁcant diﬀerence between
groups (MED diet versus lifestyle) at 2 years for insulin
(P = .04), 8-iso-PGF2α (P = .037), glucose (P = .04),
and adiponectin (P = .01) favouring lifestyle. There was no
signiﬁcant interaction of groups (intervention and advice)
per time (years). The diﬀerences remained still signiﬁcant
after adjustment for the basal body weight.
4.Discussion
Our ﬁndings indicate that prolonged adherence to a
Mediterranean-style diet, with or without caloric restriction,
inoverweightmenresultedinreducedlevelsofbiomarkersof
ageing (insulin and glucose), oxidative stress (8-iso-PGF2α),
and cardiovascular risk (cholesterol and blood pressure)
and also produced a rise in circulating level of adiponectin,
a protective factor against atherosclerosis and insulin resis-
tance [15]. Long-term intervention studies of lifestyle
changes on hard outcomes are unlikely to be performed.
However, some of the surrogate markers evaluated in
the present analysis are associated with extended life in
observational studies [1–3].
Despite the fact that the role of oxidant stress in the
pathogenesis of atherosclerosis is a hotly debated issue, in
part because of a presumed failure of antioxidants to prevent
the disease, current evidence suggests that isoprostanes
represent a biomarker that has the potential to be of great
importance in the assessment of human atherosclerotic
cardiovascular disease. In particular, 8-iso-prostaglandin F2α
(8-iso-PGF2α) is considered a reliable indicator of oxidative
stress in vivo [16, 17]. Recent evidence suggests that their
quantiﬁcation may represent an independent marker of
atherosclerotic risk [18]. Moreover, increasing evidence sug-
gests an association between oxidative stress and obesity or
insulin resistance. Keaney et al. [19] reported an association
between increasing body mass index and increasing systemic
oxidant stress; in nearly 3000 patients involved in the
Framingham Heart Study, the authors showed enhanced
IsoP formation in men and women, strongly associated with4 Cardiology Research and Practice
increasing body mass index. Data from 2,002 nondiabetic
subjects of the community-based Framingham Oﬀspring
Studyindicatethatsystemicoxidativestress isassociatedwith
insulin resistance in individuals at average or elevated risk of
diabetes (metabolic syndrome or IFG) even after accounting
for BMI [20].
Short-term (up to six months) caloric restriction in
overweight men and women produced signiﬁcant body
weight reduction associated with decreased DNA damage,
considered a surrogate marker of oxidative stress [4]. The
oxidative stress hypothesis of aging ﬁnds support from
animal studies demonstrating reduced oxidative damage
in longer-surviving, calorie-restriced rodents [21]. On the
other hand, individuals at high cardiovascular risk who
improved their diet toward a Mediterranean dietary pattern
showed signiﬁcant reductions in cellular lipid levels and
LDL oxidation [22]. This recent observation adds evidence
to the intriguing hypothesis that one important eﬀect of
Mediterranean-style diets in prolonging life [23, 24]m a yb e
associated with reduced oxidative stress and inﬂammation
[9, 10].
Adiponectin plays an important role in modulating both
insulin sensitivity and concentrations of circulating plasma
glucose and nonesteriﬁed fatty acids. A lower concentration
of circulating plasma adiponectin seems to be a good
predictor of reduced insulin sensitivity and increased risk
of type 2 diabetes [25]. In 987 diabetic women from
the Nurses’ Health Study with no history of cardiovascu-
lar disease, close adherence to a Mediterranean-type diet
associated with higher adiponectin concentrations [26].
Of the several components of the Mediterranean dietary
pattern score, alcohol, nuts, and whole grains show the
strongest association with adiponectin concentrations. In
insulin-resistant oﬀspring of obese type 2 diabetic patients,
a Mediterranean-style diet rich in monounsaturated fats
(23% MUFA) improved insulin sensitivity, and this was
associated with increased postprandial adiponectin mRNA
gene expression in peripheral adipose tissue [27].
Interestingly enough, many of the parameters that are
positively aﬀected in the intervention groups are important
risk factors for healthy survival in a large group of middle-
aged men, including overweight, and high glucose, triglyc-
eride, and blood pressure levels [3]. Given the diﬃculty of
adopting a calorie restricted diet in the long-run, it seems
important that such changes may be obtained, although to
a lesser degree, with improved quality of diet. The public
health burden of chronic diseases related to unhealthy diet
is huge and on the rise, and argues for concomitant public
health strategies and policies that aﬀect entire populations.
In conclusion, prolonged adherence to a Mediterranean-
style diet, with or without caloric restriction, in overweight
or obese men is associated with signiﬁcant amelioration
of multiple risk factors, including a better cardiovascular
risk proﬁle (less blood pressure, less total cholesterol and
triglycerides, higher HDL-cholesterol), reduced oxidative
stress (less iso-8-PGF2α), and improved insulin sensitiv-
ity (reduced HOMA and increased adiponectin levels).
These changes are ampliﬁed when MED diet is associated
with calorie restriction and increased physical activity.
As several potential risk factors for healthy and long survival
in men are modiﬁable, common approaches that target
multiple risk factors simultaneously and approaches that
enhance insulin sensitivity may improve the probability of
better health at older ages [3]. The choice of healthy diets,
as the Mediterranean-style diet is thought to be, is critical
to ﬁghting the war against chronic disease and to add
healthy years to life. This seems particularly important for
individuals who carry additional risk factors, such as type 2
diabetes mellitus, obesity, and the metabolic syndrome, and
fail, as most do, to have a consistent and long-term weight
loss.
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